Cancers national cancer institute u s. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy5

Cell Line, Tumor Tumor Cells, Cultured HT29 Cells Lymph Nodes Breast

Organisms2

Mice, Nude Vegetables

Diseases48

Neoplasms Breast Neoplasms Lung Neoplasms Prostatic Neoplasms Ovarian Neoplasms Colonic Neoplasms Stomach Neoplasms Neoplasm Metastasis Colorectal Neoplasms Neoplasm Invasiveness Pancreatic Neoplasms Neoplasm Recurrence, Local Carcinoma, Non-Small-Cell Lung Uterine Cervical Neoplasms Disease Progression Carcinoma Urinary Bladder Neoplasms Genetic Predisposition to Disease Adenocarcinoma Neoplasms, Second Primary Carcinoma, Squamous Cell Rectal Neoplasms Skin Neoplasms Carcinoma, Small Cell Kidney Neoplasms Melanoma Head and Neck Neoplasms Liver Neoplasms Genital Neoplasms, Female Gastrointestinal Neoplasms Neoplasms, Radiation-Induced Neutropenia Brain Neoplasms Bone Neoplasms Neoplasms, Experimental Thyroid Neoplasms Endometrial Neoplasms Esophageal Neoplasms Nausea Leukemia, Lymphocytic, Chronic, B-Cell Vomiting Lymphoma, Non-Hodgkin Neoplasms, Ductal, Lobular, and Medullary Mouth Neoplasms Cell Transformation, Neoplastic Fatigue Precursor Cell Lymphoblastic Leukemia-Lymphoma Miosis

Chemicals and Drugs39

Antineoplastic Agents Tumor Markers, Biological Cisplatin Paclitaxel Fluorouracil Neoplasm Proteins Cancer Vaccines Prostate-Specific Antigen Deoxycytidine Antineoplastic Agents, Phytogenic Organoplatinum Compounds Receptors, Estrogen Antimetabolites, Antineoplastic Tamoxifen Carcinogens DNA, Neoplasm RNA, Messenger Taxoids Antineoplastic Agents, Hormonal Receptor, erbB-2 Tumor Suppressor Protein p53 Antibodies, Monoclonal Cyclophosphamide Receptors, Progesterone Camptothecin Antibodies, Monoclonal, Humanized Vinblastine Anticarcinogenic Agents Antineoplastic Agents, Alkylating Quinazolines Carboplatin Topotecan Receptor, Epidermal Growth Factor Dacarbazine Antigens, Neoplasm Antibiotics, Antineoplastic Leucovorin RNA, Small Interfering Vincristine

Analytical, Diagnostic and Therapeutic Techniques and Equipment78

SEER Program Early Detection of Cancer Drug Screening Assays, Antitumor Clinical Trials as Topic Survival Rate Antineoplastic Combined Chemotherapy Protocols Survival Analysis Treatment Outcome Registries Incidence Retrospective Studies Prognosis Neoplasm Staging Follow-Up Studies Disease-Free Survival Combined Modality Therapy Risk Factors Risk Assessment Prospective Studies Drug Administration Schedule Risk Research Design Clinical Trials, Phase III as Topic Chemotherapy, Adjuvant Radiotherapy Questionnaires Multicenter Studies as Topic Kaplan-Meier Estimate Odds Ratio Logistic Models Cohort Studies Reproducibility of Results Mammography Multivariate Analysis Gene Expression Profiling Infusions, Intravenous Patient Selection Sensitivity and Specificity Xenograft Model Antitumor Assays Carcinogenicity Tests Clinical Trials, Phase II as Topic Clinical Trials, Phase I as Topic Confidence Intervals Radiotherapy, Adjuvant Maximum Tolerated Dose Predictive Value of Tests Radiotherapy Dosage Mass Screening Prevalence Neoplasms, Experimental Neoplasm Grading Oligonucleotide Array Sequence Analysis Mastectomy Reverse Transcriptase Polymerase Chain Reaction Administration, Oral Drug Evaluation, Preclinical Mastectomy, Segmental Lymph Node Excision Epidemiologic Studies Polymerase Chain Reaction Regression Analysis Cross-Sectional Studies Data Collection Probability Pilot Projects Feasibility Studies Mastectomy, Simple Neoplasm Transplantation Blotting, Western Models, Statistical Drug Evaluation Endpoint Determination Biopsy Models, Biological Mortality Population Surveillance Drug Design Palliative Care

Psychiatry and Psychology2

Smoking Cooperative Behavior

Phenomena and Processes22

Risk Drug Resistance, Neoplasm Gene Expression Regulation, Neoplastic Genetic Predisposition to Disease Dose-Response Relationship, Drug Time Factors Odds Ratio Sensitivity and Specificity Mutation Diet Maximum Tolerated Dose Genotype Cell Survival Cell Division Apoptosis Cell Cycle Probability Postmenopause Cell Proliferation Microsatellite Repeats DNA Methylation Algorithms

Disciplines and Occupations7

Medical Oncology Biomedical Research Research Design Research Translational Medical Research Radiation Oncology Drug Design

Anthropology, Education, Sociology and Social Phenomena11

National Cancer Institute (U.S.)National Institutes of Health (U.S.)National Institute for Occupational Safety and Health (U.S.)Government Programs Quality of Life National Heart, Lung, and Blood Institute (U.S.)Age Distribution Forecasting Community Networks Health Education United States Food and Drug Administration

Technology, Industry, Agriculture1

Humanities1

Quality of Life

Information Science17

SEER Program Survival Rate Registries Incidence Databases, Factual Questionnaires Information Services Databases as Topic Prevalence Community Networks Internet Data Collection Online Systems Hotlines Mortality Algorithms Terminology as Topic

Named Groups8

European Continental Ancestry Group Survivors African Americans Research Personnel Ethnic Groups Hispanic Americans African Continental Ancestry Group Infant, Newborn

Health Care74

National Cancer Institute (U.S.)National Institutes of Health (U.S.)Academies and Institutes SEER Program Clinical Trials as Topic Cancer Care Facilities Research Support as Topic Survival Rate Survival Analysis Treatment Outcome Registries Incidence Retrospective Studies Follow-Up Studies Disease-Free Survival Age Factors Risk Factors American Cancer Society Risk Assessment Prospective Studies Risk National Institute for Occupational Safety and Health (U.S.)Institute of Medicine (U.S.)Clinical Trials, Phase III as Topic Questionnaires Tissue Banks Multicenter Studies as Topic Pharmacy and Therapeutics Committee Kaplan-Meier Estimate Odds Ratio Logistic Models Cohort Studies Reproducibility of Results Multivariate Analysis Patient Selection Sex Factors Sensitivity and Specificity National Heart, Lung, and Blood Institute (U.S.)National Health Programs Clinical Trials, Phase II as Topic Age Distribution Congresses as Topic Clinical Trials, Phase I as Topic Confidence Intervals Predictive Value of Tests Financing, Government Mass Screening Ethnic Groups Confounding Factors (Epidemiology)Professional Staff Committees Prevalence Epidemiologic Studies Community Networks Health Education Practice Guidelines as Topic Health Planning Guidelines Regression Analysis Cross-Sectional Studies Occupational Exposure Data Collection Probability Health Services Accessibility International Agencies Cost-Benefit Analysis Pilot Projects Feasibility Studies Healthcare Disparities United States Food and Drug Administration Models, Statistical Guidelines as Topic Mortality Population Surveillance Program Development Palliative Care

Geographicals8

United States Canada Egypt Delaware Republic of Korea Italy Great Britain Japan

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

National Cancer Institute (U.S.)National Institutes of Health (U.S.)United States Neoplasms Academies and Institutes SEER Program Breast Neoplasms Antineoplastic Agents Early Detection of Cancer Drug Screening Assays, Antitumor Clinical Trials as Topic Cancer Care Facilities Lung Neoplasms Medical Oncology Prostatic Neoplasms Research Support as Topic Survival Rate Antineoplastic Combined Chemotherapy Protocols Survival Analysis Ovarian Neoplasms Treatment Outcome Registries Incidence Retrospective Studies Prognosis Neoplasm Staging Follow-Up Studies Colonic Neoplasms Disease-Free Survival Stomach Neoplasms Combined Modality Therapy Age Factors Neoplasm Metastasis Biomedical Research Colorectal Neoplasms Risk Factors American Cancer Society Canada Neoplasm Invasiveness Risk Assessment Pancreatic Neoplasms Prospective Studies Drug Administration Schedule Neoplasm Recurrence, Local Tumor Markers, Biological Risk Cisplatin Drug Resistance, Neoplasm Databases, Factual Carcinoma, Non-Small-Cell Lung National Institute for Occupational Safety and Health (U.S.)Gene Expression Regulation, Neoplastic Uterine Cervical Neoplasms Disease Progression Carcinoma Cell Line, Tumor Research Design Institute of Medicine (U.S.)Urinary Bladder Neoplasms Clinical Trials, Phase III as Topic Chemotherapy, Adjuvant Genetic Predisposition to Disease Radiotherapy Government Programs Paclitaxel Questionnaires Tissue Banks Multicenter Studies as Topic European Continental Ancestry Group Mice, Nude Adenocarcinoma Neoplasms, Second Primary Fluorouracil Pharmacy and Therapeutics Committee Dose-Response Relationship, Drug Survivors Time Factors Neoplasm Proteins Kaplan-Meier Estimate Quality of Life Carcinoma, Squamous Cell Smoking Odds Ratio Cancer Vaccines Logistic Models Cohort Studies Reproducibility of Results Prostate-Specific Antigen Mammography Deoxycytidine Antineoplastic Agents, Phytogenic Organoplatinum Compounds Research Multivariate Analysis Gene Expression Profiling Infusions, Intravenous Receptors, Estrogen Rectal Neoplasms Skin Neoplasms Antimetabolites, Antineoplastic

No FAQ available that match "cancers national cancer institute u s"